Day: June 27, 2021

Investigational 2.0 mg dose of Ozempic® (semaglutide) demonstrates superior reductions in blood sugar vs Ozempic® 1.0 mg in adults with type 2 diabetes in a phase 3 trial

Staff June 27, 2021

Bagsværd, Denmark, 26 June 2021 – Novo Nordisk today presented data showing that an investigational 2.0 mg dose of Ozempic®...

Intellia and Regeneron Announce Landmark Clinical Data Showing Deep Reduction in Disease-Causing Protein After Single Infusion of NTLA-2001, an Investigational CRISPR Therapy for Transthyretin (ATTR) Amyloidosis

Staff June 27, 2021

Intellia Therapeutics Logo Intellia Therapeutics Logo John Leonard, M.D., President and CEO, Intellia Therapeutics John Leonard, M.D., President and CEO,...

Sana Biotechnology Presents Data at ISSCR 2021 Virtual Annual Meeting Showing Survival of Transplanted Hypoimmune Stem Cells Without Immunosuppression in Non-Human Primates

Staff June 27, 2021

First demonstration of the survival of allogeneic iPSCs transplanted into an immunocompetent non-human primate model without the need for immune...

Day: June 27, 2021

Investigational 2.0 mg dose of Ozempic® (semaglutide) demonstrates superior reductions in blood sugar vs Ozempic® 1.0 mg in adults with type 2 diabetes in a phase 3 trial

Intellia and Regeneron Announce Landmark Clinical Data Showing Deep Reduction in Disease-Causing Protein After Single Infusion of NTLA-2001, an Investigational CRISPR Therapy for Transthyretin (ATTR) Amyloidosis

Sana Biotechnology Presents Data at ISSCR 2021 Virtual Annual Meeting Showing Survival of Transplanted Hypoimmune Stem Cells Without Immunosuppression in Non-Human Primates

Pearl Enables Advanced AI Imaging for New Ora All-in-One Dental Software Platform

Simpson Interventions Announces Appointment of Dr. Joseph Knight as CEO

WakeMed Selects Bamboo Health to Drive Improved Care Coordination for Patients

Info-Tech LIVE 2024: Featured Experts Announced to Unveil Key 2025 AI, Next-Gen IT, and Tech Trends at September Event in Las Vegas

TSI Names Angela Armstrong as Executive Vice President and General Manager of TSI Healthcare

You may have missed